Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-13 to 2024-01-05
Current total value of award: $39037.12
Description: 4563118382!TYSABRI 300 MG/15 ML VIAL 15ML